Literature DB >> 8458381

Human peripheral blood eosinophils produce and release interleukin-8 on stimulation with calcium ionophore.

R K Braun1, M Franchini, F Erard, S Rihs, I J De Vries, K Blaser, T T Hansel, C Walker.   

Abstract

We present evidence that human blood eosinophils produce interleukin (IL)-8 when stimulated with calcium ionophore. Following in vitro culture of 99% pure eosinophils with calcium ionophore, released IL-8 was detectable by enzyme-linked immunosorbent assay in supernatants. Eosinophil IL-8 production was considerably greater than that of IL-3 or granulocyte macrophage colony-stimulating factor. Furthermore, eosinophil production of IL-8 in the presence of calcium ionophore could be inhibited with the immunomodulating agent cyclosporin A and the protein synthesis inhibitor cycloheximide. In addition, following stimulation of highly purified blood eosinophils with calcium ionophore, IL-8 mRNA was detectable after polymerase chain reaction amplification. In comparison with other cells on stimulation with calcium ionophore, eosinophils produce about half as much IL-8 as neutrophils but significantly more than purified T cells. In contrast to monocytes and neutrophils, IL-8 production was not inducible with IL-1 or tumor necrosis factor. Finally, following calcium ionophore stimulation blood eosinophils were shown to contain cytoplasmic IL-8 by employing a monoclonal antibody against IL-8 in conjunction with immunohistochemistry. These observations demonstrate that eosinophils are capable of IL-8 production and release, which may contribute to defense against parasites and to the pathophysiology of allergic and asthmatic disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8458381     DOI: 10.1002/eji.1830230429

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  18 in total

1.  Expression of IL-8 in Kawasaki disease.

Authors:  T Asano; S Ogawa
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

Review 2.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

3.  Enhanced production of IL-8 in chronic but not in early ileal lesions of Crohn's disease (CD).

Authors:  E Brandt; J F Colombel; N Ectors; L Gambiez; D Emilie; K Geboes; M Capron; P Desreumaux
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

Review 4.  Mechanisms of eosinophil cytokine release.

Authors:  Christianne Bandeira-Melo; Peter F Weller
Journal:  Mem Inst Oswaldo Cruz       Date:  2005-06-14       Impact factor: 2.743

Review 5.  Alpha 4 integrin-induced cytokine production and eosinophil function.

Authors:  D H Broide
Journal:  Springer Semin Immunopathol       Date:  1995

Review 6.  Eosinophils in the 1990s: new perspectives on their role in health and disease.

Authors:  A J Wardlaw
Journal:  Postgrad Med J       Date:  1994-08       Impact factor: 2.401

Review 7.  Activation of Human Eosinophils with Nanoparticles: a New Area of Research.

Authors:  Marion Vanharen; Denis Girard
Journal:  Inflammation       Date:  2020-02       Impact factor: 4.092

8.  Synergism of gamma interferon and interleukin-5 in the control of murine filariasis.

Authors:  Michael Saeftel; Manuela Arndt; Sabine Specht; Lars Volkmann; Achim Hoerauf
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

9.  Eosinophil accumulation induced by human interleukin-8 in the guinea-pig in vivo.

Authors:  P D Collins; V B Weg; L H Faccioli; M L Watson; R Moqbel; T J Williams
Journal:  Immunology       Date:  1993-06       Impact factor: 7.397

10.  C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation.

Authors:  P J Daffern; P H Pfeifer; J A Ember; T E Hugli
Journal:  J Exp Med       Date:  1995-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.